Key points from article :
A genetically edited pig kidney kept a US man off dialysis for a record 271 days and then served as a "bridge" until he could receive a human kidney, according to a team led by Leonardo Riella and Tatsuo Kawai at Mass General Brigham in Boston. Tim Andrews, who had end-stage kidney disease caused by type 2 diabetes, was 66 when he received the organ in January 2025. His case is the longest dialysis-free survival after a pig kidney transplant in a living person, and the first in which a patient went on to a human transplant.
The kidney came from a pig with 69 genetic edits designed to stop the human immune system attacking it and to disable viruses hidden in pig DNA. It worked immediately, an early episode of rejection was treated successfully, and no pig infections were passed on. After around six months, however, blood vessels in the kidney began to be damaged, its function declined, and it was removed in October 2025. Andrews then spent 82 days back on dialysis before receiving a kidney from a human donor in January 2026, which is working well.
More than 100,000 people are on the US transplant waiting list, most of them needing a kidney, and many die before an organ becomes available. The team says pig kidneys could first help patients get off dialysis while they wait, and might later become a long-term treatment in their own right.
The doctors say it is not clear why the kidney eventually failed, as there were no signs of antibodies attacking it, and the findings come from a single patient. Larger clinical trials of pig kidney transplants are being prepared.
The research was led by Leonardo Riella and Tatsuo Kawai at Mass General Brigham and published in The Lancet.


